<p>Ranibizumab is indicated for the treatment of patients with:</p>

<ul>
	<li>Neovascular (Wet) Age-Related Macular Degeneration (AMD)</li>
	<li>Macular Edema Following Retinal Vein Occlusion (RVO)</li>
	<li>Diabetic Macular Edema (DME)</li>
	<li>Diabetic Retinopathy (Non Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR)) in patients with Diabetic Macular Edema (DME)</li>
	<li>Myopic Choroidal Neovascularization (mCNV)</li>
</ul>